Biopharma Plasma LLC
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of BP-SCIG 20% in Patients With Primary Immunodeficiency (PID) (NCT07346859) | Biopharma Plasma LLC | 2025-12-17 |
| Intravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytopenia (ITP) in Adults (NCT05422365) | Biopharma Plasma LLC | 2022-07-26 |
| Human Anti-D (rh) Immunoglobulin (Rhesoglobin) Efficacy, Safety and Some Pharmacokinetics Parameters in Pregnant Women (NCT05245734) | Biopharma Plasma LLC | 2022-02-08 |
| Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex Treatment (NCT04500067) | Biopharma Plasma LLC | 2020-05-07 |
Track Biopharma Plasma LLC automatically
Every clearance here is in the API, with alerts when new ones post.